Liên Minh Châu Âu -
Tiếng Na Uy -
EMA (European Medicines Agency)
herwenda
sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - antineoplastiske midler - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).
Liên Minh Châu Âu -
Tiếng Na Uy -
EMA (European Medicines Agency)
jaypirca
eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcelle - protein kinase hemmere - treatment of mantle cell lymphoma (mcl).
Na Uy -
Tiếng Na Uy -
Statens legemiddelverk
fosamax 70 mg
n.v. organon - kloosterstraat - alendronatnatriumtrihydrat - tablett - 70 mg
Na Uy -
Tiếng Na Uy -
Statens legemiddelverk
binosto 70 mg
pharmaprim ab - alendronatnatriumtrihydrat - brusetablett - 70 mg
Na Uy -
Tiếng Na Uy -
Statens legemiddelverk
bosentan cipla 125 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 125 mg
Na Uy -
Tiếng Na Uy -
Statens legemiddelverk
bosentan cipla 62.5 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg
Liên Minh Châu Âu -
Tiếng Na Uy -
EMA (European Medicines Agency)
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - Øyemidler - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
Liên Minh Châu Âu -
Tiếng Na Uy -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Øyemidler - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Liên Minh Châu Âu -
Tiếng Na Uy -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).